BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23528160)

  • 1. Second primary colorectal cancer in the era of prevalent screening and imaging.
    Bae S; Asadi M; Jones I; McLaughlin S; Bui A; Steele M; Tie J; Gibbs P
    ANZ J Surg; 2013 Dec; 83(12):963-7. PubMed ID: 23528160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
    Cluze C; Delafosse P; Seigneurin A; Colonna M
    Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer.
    Srinivasan R; Yang YX; Rubin SC; Morgan MA; Lewis JD
    Am J Gastroenterol; 2005 Dec; 100(12):2759-64. PubMed ID: 16393232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of the four major cancers in South Dakota.
    Clarke J
    S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for breast and colorectal cancers subsequent to cancer of the endometrium in a population-based case series.
    Re A; Taylor TH; DiSaia PJ; Anton-Culver H
    Gynecol Oncol; 1997 Aug; 66(2):255-7. PubMed ID: 9264572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
    Schoen RE; Weissfeld JL; Kuller LH
    Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance and monitoring of adult cancer survivors.
    Choi M; Craft B; Geraci SA
    Am J Med; 2011 Jul; 124(7):598-601. PubMed ID: 21683826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
    Laitinen VH; Wahlfors T; Saaristo L; Rantapero T; Pelttari LM; Kilpivaara O; Laasanen SL; Kallioniemi A; Nevanlinna H; Aaltonen L; Vessella RL; Auvinen A; Visakorpi T; Tammela TL; Schleutker J
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):452-60. PubMed ID: 23292082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of cancer in the United States.
    Cresanta JL
    Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom pattern and diagnostic work-up of malignancy at first symptom presentation as related to level of care. A retrospective study from the primary health care centre area of Kungsbacka, Sweden.
    Månsson J; Björkelund C; Hultborn R
    Neoplasma; 1999; 46(2):93-9. PubMed ID: 10466432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary cancers after a lung carcinoid primary: a population-based analysis.
    Cote ML; Wenzlaff AS; Philip PA; Schwartz AG
    Lung Cancer; 2006 Jun; 52(3):273-9. PubMed ID: 16567020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma and additional primary cancers.
    Retsas S; Mohith A; Bell J; Horwood N; Alexander H
    Melanoma Res; 2000 Apr; 10(2):145-52. PubMed ID: 10803715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in in-patient hospital utilization and surgical procedures for breast, prostate, lung and colorectal cancers in Canada.
    Neutel CI; Gao RN; Wai E; Gaudette LA
    Cancer Causes Control; 2005 Dec; 16(10):1261-70. PubMed ID: 16215877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is gynecological cancer a new indication for surveillance colonoscopy in Korea?
    Chang JH; Choi HS; Choi JS; Park DI; Seo HI; Yang MH; Sohn HJ; Lee SY; Jeen YT; Ji JS; Jang BI; Shin JE; Eun CS; Back IH
    Hepatogastroenterology; 2012 May; 59(115):727-30. PubMed ID: 22469715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
    Mulder SA; Kranse R; Damhuis RA; Ouwendijk RJ; Kuipers EJ; van Leerdam ME
    Dis Colon Rectum; 2012 May; 55(5):522-31. PubMed ID: 22513430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing cancer in the bush: a mixed methods study of GP and specialist diagnostic intervals in rural Western Australia.
    Emery JD; Walter FM; Gray V; Sinclair C; Howting D; Bulsara M; Bulsara C; Webster A; Auret K; Saunders C; Nowak A; Holman D
    Fam Pract; 2013 Oct; 30(5):541-50. PubMed ID: 23699107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.